Your browser doesn't support javascript.
loading
Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells.
Nakatsu, Yusuke; Yamamotoya, Takeshi; Ueda, Koji; Ono, Hiraku; Inoue, Masa-Ki; Matsunaga, Yasuka; Kushiyama, Akifumi; Sakoda, Hideyuki; Fujishiro, Midori; Matsubara, Akio; Asano, Tomoichiro.
Affiliation
  • Nakatsu Y; Department of Medical Science, Graduate School of Medicine, Hiroshima University, Hiroshima City, Hiroshima, Japan.
  • Yamamotoya T; Department of Medical Science, Graduate School of Medicine, Hiroshima University, Hiroshima City, Hiroshima, Japan.
  • Ueda K; Department of Medical Science, Graduate School of Medicine, Hiroshima University, Hiroshima City, Hiroshima, Japan.
  • Ono H; Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, 260-8670, Japan.
  • Inoue MK; Department of Medical Science, Graduate School of Medicine, Hiroshima University, Hiroshima City, Hiroshima, Japan.
  • Matsunaga Y; Center for Translational Research in Infection & Inflammation, School of Medicine, Tulane University, New Orleans, LA, USA.
  • Kushiyama A; Department of Pharmacotherapy, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose City, Tokyo, 204-8588, Japan.
  • Sakoda H; The Division of Neurology, Respirology, Endocrinology, and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Kiyotake, Miyazaki, Japan.
  • Fujishiro M; Division of Diabetes and Metabolic Diseases, Nihon University School of Medicine, Itabashi, Tokyo, 173-8610, Japan.
  • Matsubara A; Department of Urology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.
  • Asano T; Department of Medical Science, Graduate School of Medicine, Hiroshima University, Hiroshima City, Hiroshima, Japan. Electronic address: tasano@hiroshima-u.ac.jp.
Cancer Lett ; 470: 106-114, 2020 02 01.
Article in En | MEDLINE | ID: mdl-31678165
Pin1 is one member of a group consisting of three prolyl isomerases. Pin1 interacts with the motif containing phospho-Ser/Thr-Pro of substrates and enhances cis-trans isomerization of peptide bonds, thereby controlling the functions of these substrates. Importantly, the Pin1 expression level is highly upregulated in most cancer cells and correlates with malignant properties, and thereby with poor outcomes. In addition, Pin1 was revealed to promote the functions of multiple oncogenes and to abrogate tumor suppressors. Accordingly, Pin1 is well recognized as a master regulator of malignant processes. Recent studies have shown that Pin1 also binds to a variety of metabolic regulators, such as AMP-activated protein kinase, acetyl CoA carboxylase and pyruvate kinase2, indicating Pin1 to have major impacts on lipid and glucose metabolism in cancer cells. In this review, we focus on the roles of Pin1 in metabolic reprogramming, such as "Warburg effects", of cancer cells. Our aim is to introduce these important roles of Pin1, as well as to present evidence supporting the possibility of Pin1 inhibition as a novel anti-cancer strategy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: NIMA-Interacting Peptidylprolyl Isomerase / Glycolysis / Neoplasms Limits: Animals / Humans Language: En Journal: Cancer Lett Year: 2020 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: NIMA-Interacting Peptidylprolyl Isomerase / Glycolysis / Neoplasms Limits: Animals / Humans Language: En Journal: Cancer Lett Year: 2020 Document type: Article Affiliation country: Country of publication: